Grünenthal has appointed Jan Adams as its new chief commercial officer, effective October 1. Dr. Adams, currently the chief ...

Sino-American biotech Regor Pharmaceuticals has entered into a definitive purchase agreement whereby Swiss pharma major Roche ...

India is set to complete 50 new greenfield pharma manufacturing plants in the next two years under its Production-linked ...

US RNAi therapeutics company Alnylam Pharmaceuticals has released two new data sets from the HELIOS-B Phase III study of ...

Global leaders at the 79th UN General Assembly approved a political declaration on antimicrobial resistance (AMR), targeting ...

Cambridge, USA-based Prime Medicine saw its shares rocket more than 38% to $4.78 today, as it revealed a strategic research ...

The number of clinical trials of new drugs in Russia is steadily declining, which could be mainly related with the overall ...

Johnson & Johnson reported long-term Phase III CARTITUDE-4 study results showing that a single infusion of Carvykti ...

The US Food and Drug Administration (FDA) granted traditional approval for US pharma major Eli Lilly’s Retevmo (selpercatinib ...

China-based Asieris Pharmaceuticals announced that the international multicenter Phase III clinical study data of its ...

Swiss pharma giant Roche has announced positive top-line results from the Phase III REGENCY study of Gazyva/Gazyvaro ...

USA-based engineered regulatory T cells (Tregs) company GentiBio today announced the appointment of Dr Mark Bach as chief ...